Skip to content
Screener

Jade Biosciences JBIO Q1 2025 earnings

Reported April 25, 2025 · Before market open

EPS-$0.09Beat by $8.31
EPS estimate-$8.40

Next report

Nov 12, 2026 (in a month)
EPS estimate-$0.73

Financials

Q1 2025

Income statement

See full
Operating income-$23.4M+5.0%
Net income-$38.2M-64.6%
EPS (diluted)-$12.10-1,358%

Balance sheet

See full
Cash & equivalents$44.2M+385%
Total debt$312.0K-59.7%
Total equity-$83.5M-192%
Total assets$77.5M-27.4%

Cash flow

See full
Operating cash flow-$18.8M+20.8%
CapEx$5.0K—
Free cash flow-$18.8M—

FAQ

When did Jade Biosciences report Q1 2025 earnings?
Jade Biosciences (JBIO) reported Q1 2025 earnings on April 25, 2025 before market open.
What were Jade Biosciences's Q1 2025 revenue and EPS?
Jade Biosciences reported eps of $-0.09 for Q1 2025.
Did Jade Biosciences beat estimates in Q1 2025?
EPS beat the consensus estimate of $-8.40 by $8.31.
Where can I find Jade Biosciences's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-005278) and the 10-Q periodic report (0001558370-25-005564) directly on SEC EDGAR. The filing index links above go to sec.gov.